Quantcast

Latest ViaCyte Inc. Stories

2014-08-19 08:30:47

Company Plans to Immediately Initiate Phase 1/2 Clinical Trial SAN DIEGO, Aug.

2014-07-17 16:25:37

NEW YORK, July 17, 2014 /PRNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today ViaCyte, Inc., a leading regenerative medicine

2014-07-17 08:30:21

SAN DIEGO, July 17, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, today announced that

2014-07-08 08:32:11

SAN DIEGO, July 8, 2014 /PRNewswire/ -- ViaCyte, Inc.

2014-05-29 08:30:21

SAN DIEGO, May 29, 2014 /PRNewswire/ -- ViaCyte, Inc., a regenerative medicine company focused on developing a cell replacement therapy for the treatment of patients with insulin-dependent diabetes,

2014-02-06 08:29:38

-- Potentially transformative therapy for individuals with type 1 diabetes nearing major milestone -- NEW YORK and SAN DIEGO, Feb.


Word of the Day
dipsas
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.